Trial Condition(s):

Hypertension, Pulmonary

Non-interventional study on compliance of inhaled treatment with Ventavis in patient with pulmonary hypertension (IVENT)

Bayer Identifier:

16777

ClinicalTrials.gov Identifier:

NCT01971450

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Local, prospective, multicenter, non-comparative, non-interventional, observational study. It is planed to assess compliance of patients with PH (pulmonary hypertension) with the physician’s recommendation in real practice.

Inclusion Criteria
- Male and female patients ≥ 18 years old 
 - Diagnosis of PH 
 - Planned or current treatment with Ventavis (not more than 6 month)
Exclusion Criteria
- Contraindications for the use of Ventavis in accordance with the local product information

Trial Summary

Enrollment Goal
89
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Ventavis (Iloprost, BAYQ6256)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Russia

Status
Completed
 

Trial Design